Psychological stress in IBD: New insights into pathogenic and therapeutic implications

Gut

Volumn 54, Issue 10, 2005, Pages 1481-1491

  Mawdsley, J E ^b   Rampton, D S ^a,b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; SUBSTANCE P;

COLITIS; DEPRESSION; ENTERITIS; GASTROINTESTINAL MOTILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIFE EVENT; MENTAL STRESS; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; REVIEW;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LIFE CHANGE EVENTS; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL;

EID: 25444470762     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.064261     Document Type: Review

References (149)

1. Ahmad T, Tamboli CP, Jewell D, et al. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 2004;126:1533-49.
2. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 2001;120:622-35.
3. Hugot JP. Genetic origin of IBD. Inflamm Bowel Dis 2004;10(suppl 1):S11-15.
4. Brown CH. Acute emotional crises and ulcerative colitis. Report of seven cases. Am J Dig Dis 1963;8:525-36.
5. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992;267:1244-52.
6. Carrasco GA, Van de Kar LD. Neuroendocrine pharmacology of stress. Eur J Pharmacol 2003;463:235-72.
7. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996;334:1106-15.
8. Ader R, Cohen N, Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 1995;345:99-l03.
9. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut 2000;47:861-9.
10. Reichlin S. Neuroendocrine-immune interactions. N Engl J Med 1993;329:1246-53.
11. Barnes PJ. Molecular mechanisms of corticosteroids in allergic diseases. Allergy 2001;56:928-36.
12. Ray A, Sehgal PB. Cytokines and their receptors: molecular mechanism of interleukin-6 gene repression by glucocorticoids. J Am Soc Nephrol 1992;2(suppl):S214-21.
13. Joyce DA, Gimblett G, Steer JH. Targets of glucocorticoid action on TNF-alpha release by macrophages. Inflamm Res 2001;50:337-40.
14. Franchimont D, Kino T, Galon J, et al. Glucocorticoids and inflammation revisited: the state of the art. NIH Clinical Staff Conference. Neuroimmunomodulation 2003;10:247-60.
15. Brattsand R, Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Tiber 1996;10(suppl 2):81-90.
16. Amsterdam A, Tajima K, Sasson R. Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem Pharmacol 2002;64:843-50.
17. Renz H, Henke A, Hofmann P, et al. Sensitization of rat alveolar macrophages to enhanced TNF-alpha release by in vivo treatment with dexamethasone. Cell Immunol 1992;144:249-57.
18. Sondergaard SR, Ostrowski K, Ullum H, et al. Changes in plasma concentrations of interleukin-6 and interleukin-1 receptor antagonists in response to adrenaline infusion in humans. Eur J Appl Physiol 2000;83:95-8.
19. Van der PT, Lowry SF. Lipopolysaccharide-induced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone. Infect Immun 1997;65:2378-81.
20. Siegmund B, Eigler A, Hartmann G, et al. Adrenaline enhances LPS-induced IL-10 synthesis: evidence for protein kinase A-mediated pathway. Int J Immunopharmacol 1998;20:57-69.
21. Kappel M, Poulsen TD, Galbo H, et al. Effects of elevated plasma noradrenaline concentration on the immune system in humans. Eur J Appl Physiol Occup Physiol 1998;79:93-8.
22. Van der PT, Lowry SF. Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10. Am J Physiol 1997;273(6 Pt 2):R1885-90.
23. Straub RH, Dhabhar FS, Bijlsma JW, et al. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthritis Rheum 2005;52:16-26.
24. Irwin M, Daniels M, Weiner H. Immune and neuroendocrine changes during bereavement. Psychiatr Clin North Am 1987;10:449-65.
25. Frank MG, Wieseler Frank JL, Hendricks SE, et al. Age at onset of major depressive disorder predicts reductions in NK cell number and activity. J Affect Disord 2002;71:159-67.
26. Chu L, Tian S, Chen H et al. Study on natural killer cell subset and activity in patients with depression. Zhonghua Yi Xue Za Zhi 2002;82:830-1.
27. Fortes C, Farchi S, Forastiere F, et al. Depressive symptoms lead to impaired cellular immune response. Psychother Psychosom 2003;72:253-60.
28. Schleifer SJ, Bartlett JA, Keller SE, et al. Immunity in adolescents with major depression. J Am Acad Child Adolesc Psychiatry 2002;41:1054-60.
29. Danner M, Kasl SV, Abramson JL, et al. Association between depression and elevated C-reactive protein. Psychosom Med 2003;65:347-56.
30. Sajadieh A, Nielsen OW, Rasmussen V, et al. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004;25:363-70.
31. Marsland AL, Manuck SB, Fazzari W, et al. Stability of individual differences in cellular immune responses to acute psychological stress. Psychosom Med 1995;57:295-8.
32. Kirschbaum C, Klauer T, Filipp SH, et al. Sex-specific effects of social support on cortisol and subjective responses to acute psychological stress. Psychosom Med 1995;57:23-31.
33. Valori RM, Kumar D, Wingate DL. Effects of different types of stress and of "prokinetic" drugs on the control of the fasting motor complex in humans. Gastroenterology 1986;90:1890-900.
34. Pike JL, Smith TL, Hauger RL, et al. Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans. Psychosom Med 1997;59:447-57.
35. Jorgensen LS, Bonlokke L, Christensen NJ. Life strain, life events, and autonomic response to a psychological stressor in patients with chronic upper abdominal pain. Scand J Gastroenterol 1986;21:605-13.
36. Gold SM, Zakowski SG, Valdimarsdottir HB, et al. Stronger endocrine responses after brief psychological stress in women at familial risk of breast cancer. Psychoneuroendocrinology 2003;28:584-93.
37. Rohleder N, Wolf JM, Piel M, et al. Impact of oral contraceptive use on glucocorticoid sensitivity of pro-inflammatory cytokine production after psychosocial stress. Psychoneuroendocrinology 2003;28:261-73.
38. Golden CJ. The measurement of creativity by the Stroop Color and Word Test. J Pers Assess 1975;39:502-6.
39. Richter SD, Schurmeyer TH, Schedlowski M, et al. Time kinetics of the endocrine response to acute psychological stress. J Clin Endocrinol Metab 1996;81:1956-60.
40. Maes M, Song C, Lin A, et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 1998;10:313-18.
41. Goebel MU, Mills PJ, Irwin MR, et al. Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways. Psychosom Med 2000;62:591-8.
42. Ackerman KD, Martino M, Heyman R, et al. Stressor-induced alteration of cytokine production in multiple sclerosis patients and controls. Psychosom Med 1998;60:484-91.
43. Jacobs R, Pawlak CR, Mikeska E, et al. Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure. Rheumatology (Oxford) 2001;40:868-75.
44. Steptoe A, Willemsen G, Owen N, et al. Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin Sci (Lond) 2001;101:185-92.
45. Schmid-Ott G, Jaeger B, Meyer S, et al. Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison with healthy controls. J Allergy Clin Immunol 2001;108:455-62.
46. Herbert TB, Cohen S, Marsland AL, et al. Cardiovascular reactivity and the course of immune response to an acute psychological stressor. Psychosom Med 1994;56:337-44.
47. Mawdsley JE, Jenkins DG, Macey MG, et al. Natural killer cell numbers are increased by stress and decreased by hypnotherapy in patients with ulcerative colitis Gut 2005;54(suppl II):A23.
48. Naesh O, Haedersdal C, Hindberg I, et al. Platelet activation in mental stress. Clin Physiol 1993;13:299-307.
49. Wallen NH, Goodall AH, Li N, et al. Activation of haemostasis by exercise, mental stress and adrenaline: effects on platelet sensitivity to thrombin and thrombin generation. Clin Sci (Lond) 1999;97:27-35.
50. Malkoff SB, Muldoon MF, Zeigler ZR, et al. Blood platelet responsivity to acute mental stress. Psychosom Med 1993;55:477-82.
51. Mawdsley JE, Macey MG, Rampton DS. Acute psychological stress increases platelet activation and platelet-leucocyte aggregate formation in patients with inactive ulcerative colitis. Gut 2005;54(suppl II):A91.
52. Collins CE, Cahill MR, Newland AC, et al. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994;106:840-5.
53. Collins CE, Rampton DS. Review article: platelets in inflammatory bowel disease-pathogenetic role and therapeutic implications. Aliment Pharmacol Ther 1997;11:237-47.
54. Kawano TA, Aoki N, Homori M, et al. Mental stress and physical exercise increase platelet-dependent thrombin generation. Heart Vessels 2000;15:280-8.
55. Steptoe A, Magid K, Edwards S, et al. The influence of psychological stress and socioeconomic status on platelet activation in men. Atherosclerosis 2003;168:57-63.
56. Irving PM, Macey MG, Shah U, et al. Formation of platelet-leukocyte aggregates in inflammatory bowel disease. Inflamm Bowel Dis 2004;10:361-72.
57. Pawlak CR, Jacobs R, Mikeska E, et al. Patients with systemic lupus erythematosus differ from healthy controls in their immunological response to acute psychological stress. Brain Behav Immun 1999;13:287-302.
58. Lusyne P, Page H, Lievens J. Mortality following conjugal bereavement, Belgium 1991-96: the unexpected effect of education. Popul Stud (Camb) 2001;55:281-9.
59. Kang DH, Coe CL, McCarthy DO. Academic examinations significantly impact immune responses, but not lung function, in healthy and well-managed asthmatic adolescents. Brain Behav Immun 1996;10:164-81.
60. Engel GL. Psychological factors in ulcerative colitis in man and gibbon. Gastroenterology 1969;57:362-5.
61. Alexander t. An objective study of psychological factors in ulcerative colitis in children. Lancet 1965;85:22-4.
62. Robertson DA, Ray J, Diamond I, et al. Personality profile and affective state of patients with inflammatory bowel disease. Gut 1989;30:623-6.
63. Helzer JE, Stillings WA, Chammas S, et al. A controlled study of the association between ulcerative colitis and psychiatric diagnoses. Dig Dis Sci 1982;27:513-18.
64. Helzer JE, Chammas S, Norland CC, et al. A study of the association between Crohn's disease and psychiatric illness. Gastroenterology 1984;86:324-30.
65. North CS, Clouse RE, Spitznagel EL, et al. The relation of ulcerative colitis to psychiatric factors: a review of findings and methods. Am J Psychiatry 1990;147:974-81.
66. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004;66:79-84.
67. Feagan BG, McDonald JW, Koval JJ. Therapeutics and inflammatory bowel disease: a guide to the interpretation of randomized controlled trials. Gastroenterology 1996;110:275-83.
68. Meyers S, Janowitz HD. "Natural history" of Crohn's disease. An analytic review of the placebo lesson. Gastroenterology 1984;87:1189-92.
69. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
70. Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut 1998;43:29-32.
71. Paar GH, Bezzenberger U, Lorenz-Meyer H. The correlation of psychosocial stress and disease activity in patients with Crohn disease and ulcerative colitis. Z Gastroenterol 1988;26:648-57.
72. Fava GA, Pavan L. Large bowel disorders. I. Illness configuration and life events. Psychother Psychosom 1976;27:93-9.
73. North CS, Alpers DH, Helzer JE, et al. Do life events or depression exacerbate inflammatory bowel disease? A prospective study. Ann Intern Med 1991;114:381-6.
74. von Wietersheim J, Kohler T, Feiereis H. Relapse-precipitating life events and feelings in patients with inflammatory bowel disease. Psychother Psychosom 1992;58:103-12.
75. Bitton A, Sewitch MJ, Peppercorn MA, et al. Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol 2003;98:2203-8.
76. Mardini HE, Kip KE, Wilson JW. Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci 2004;49:492-7.
77. Bach O, Wild HJ. Life stress events preceding illness episodes in multiple sclerosis and ulcerative colitis - a comparison. Z Gesamte Hyg 1990;36:442-3.
78. Duffy LC, Zielezny MA, Marshall JR, et al. Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. behav Med 1991;17:101-10.
79. Tocchi A, Lepre L, Liotta G, et al. Familial and psychological risk factors of ulcerative colitis. Ital J Gastroenterol Hepatol 1997;29:395-8.
80. Li J, Norgard B, Precht DH, et al. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark. Am J Gastroenterol 2004;99:1129-33.
81. Levenstein S, Prantera C, Varvo V, et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000;95:1213-20.
82. Levenstein S, Prantera C, Varvo V, et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol 1994;89:1219-25.
83. Garrett VD, Brantley PJ, Jones GN, et al. The relation between daily stress and Crohn's disease. J Behav Med 1991;14:87-96.
84. Greene BR, Blanchard EB, Wan CK. Long-term monitoring of psychosocial stress and symptomatology in inflammatory bowel disease. Behav Res Ther 1994;32:217-26.
85. Santos J, Saperas E, Nogueiras C, et al. Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology 1998;114:640-8.
86. Peck OC, Wood JD. Brain-gut interactions in ulcerative colitis. Gastroenterology 2000;118:807-8.
87. Kemler MA, Barendse GA, van Kleef M. Relapsing ulcerative colitis associated with spinal cord stimulation. Gastroenterology 1999;117:215-17.
88. Bjorck S, Dahlstrom A, Johansson L, et al. Treatment of the mucosa with local anaesthetics in ulcerative colitis. Agents Actions, 1992; Spec NoC60-72.
89. Lechin F, van der DB, Insausti CL, et al. Treatment of ulcerative colitis with clonidine. J Clin Pharmacol 1985;25:219-26.
90. Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994;330:811-15.
91. Bjorck S, Dahlstrom A, Ahlman H. Treatment of distal colitis with local anaesthetic agents. Pharmacol Toxicol 2002;90:173-80.
92. Straub RH, Vogl D, Gross V, et al. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease. Am J Gastroenterol 1998;93:2197-202.
93. Straub RH, Herfarth H, Falk W, et al. Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease? J Neuroimmunol 2002;126:116-25.
94. Straub RH, Antoniou E, Zeuner M, et al. Association of autonomic nervous system hyperreflexia and systemic inflammation in patients with Crohn's disease and ulcerative colitis. J Neuroimmunol 1997;80:149-57.
95. Rao SS, Hatfield RA, Suls JM, et al. Psychological and physical stress induce differential effects on human colonic motility. Am J Gastroenterol 1998;93:985-90.
96. Barclay GR, Turnberg LA. Effect of psychological stress on salt and water transport in the human jejunum. Gastroenterology 1987;93:91-7.
97. Barclay GR, Turnberg LA. Effect of cold-induced pain on salt and water transport in the human jejunum. Gastroenterology 1988;94:994-8.
98. Gonlachanvit S, Rhee J, Sun WM, et al. Effect of acute acoustic stress on anorectal function sensation in healthy human. Neurogastroenterol Motil 2005;17:222-8.
99. Murray CD, Flynn J, Ratcliffe L, et al. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology 2004;127:1695-703.
100. Greenwood-Van Meerveld B, Gibson MS, Johnson AC, et al. NK1 receptor-mediated mechanisms regulate colonic hypersensitivity in the guinea pig. Pharmacol Biochem Behav 2003;74(4):1005-13.
101. Raithel M, Schneider HT, Hahn EG. Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease. Scand J Gastroenterol 1999;34:496-503.
102. O'Connor TM, O'Connell J, O'Brien DI, et al. The role of substance P in inflammatory disease. J Cell Physiol 2004;201:167-80.
103. Wood JD, Peck OC, Tefend KS, et al. Evidence that colitis is initiated by environmental stress and sustained by fecal factors in the cotton-top tamarin (Saguinus oedipus). Dig Dis Sci 2000;45:385-93.
104. Stout C, Snyder RL. Ulcerative colitis-like lesion in Siamang gibbons. Gastroenterology 1969;57:256-61.
105. Newport DJ, Stowe ZN, Nemeroff CB. Parental depression: animal models of an adverse life event. Am J Psychiatry 2002;159:1265-83.
106. Gue M, Bonbonne C, Fioramonti J, et al. Stress-induced enhancement of colitis in rats: CRF and arginine vasopressin are not involved. Am J Physiol 1997;272(1 Pt 1):G84-91.
107. Collins SM, McHugh K, Jacobson K, et al. Previous inflammation alters the response of the rat colon to stress. Gastroenterology 1996;111:1509-15.
108. Qiu BS, Vallance BA, Blennerhassett PA, et al. The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nat Med 1999;5:1178-82.
109. Milde AM, Enger O, Murison R. The effects of postnatal maternal separation on stress responsivity and experimentally induced colitis in adult rats. Physiol Behav 2004;81:71-84.
110. Sternberg EM, Young WS III, Bernardini R, et al. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-inducea arthritis in Lewis rats. Proc Natl Acad Sci U S A 1989;86:4771-5.
111. Million M, Tache Y, Anton P. Susceptibility of Lewis and Fischer rats to stress-induced worsening of TNB-colitis: protective role of brain CRF. Am J Physiol 1999;276(4 Pt 1):G1027-36.
112. Elson CO. Genes, microbes, and T cells-new therapeutic targets in Crohn's disease. N Engl J Med 2002;346:614-16.
113. Kiliaan AJ, Saunders PR, Bijlsma PB, et al. Stress stimulates transepithelial macromolecular uptake in rat jejunum. Am J Physiol 1998;275(5 Pt 1):G1037-44.
114. Santos J, Saunders PR, Hanssen NP, et al. Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am J Physiol 1999;277(2 Pt 1):G391-9.
115. Soderholm JD, Yates DA, Gareau MG, et al. Neonatal maternal separation predisposes adult rats to colonic barrier dysfunction in response to mild stress. Am J Physiol Gastrointest Liver Physiol 2002;283:G1257-63.
116. Saunders PR, Hanssen NP, Perdue MH. Cholinergic nerves mediate stress-induced intestinal transport abnormalities in Wistar-Kyoto rats. Am J Physiol 1997;273(2 Pt 1):G486-90.
117. Santos J, Benjamin M, Yang PC, et al. Chronic stress impairs rat growth and jejunal epithelial barrier function: role of mast cells. Am J Physiol Gastrointest Liver Physiol 2000;278:G847-54.
118. Eutamene H, Theodorou V, Fioramonti J, et al. Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats. J Physiol 2003;553(Pt 3):959-66.
119. Velin AK, Ericson AC, Braaf Y, et al. Increased antigen and bacterial uptake in follicle associated epithelium induced by chronic psychological stress in rats. Gut 2004;53:494-500.
120. Soderholm JD, Yang PC, Ceponis P, et al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology 2002;123:1099-108.
121. Chen C, Brown DR, Xie Y, et al. Catecholamines modulate Escherichia coli O157:H7 adherence to murine cecal mucosa. Shock 2003;20:183-8.
122. Green BT, Lyte M, Kulkarni-Narla A, et al. Neuromodulation of enteropathogen internalization in Peyer's patches from porcine jejunum. J Neuroimmunol 2003;141(1-2):74-82.
123. Ferrier L, Mazelin L, Cenac N, et al. Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice. Gastroenterology 2003;125:795-804.
124. Soderholm JD, Streutker C, Yang PC, et al. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha. Gut 1994;53:1817-24.
125. Enck P, Merlin V, Erckenbrecht JF, et al. Stress effects on gastrointestinal transit in the rat. Gut 1989;30:455-9.
126. Tache Y, Martinez V, Million M, et al. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol 2001;280:G173-7.
127. Saunders PR, Kosecka U, McKay DM, et al. Acute stressors stimulate ion secretion and increase epithelial permeability in rat intestine. Am J Physiol 1994;267:G794-9.
128. Castagliuolo I, Lamont JT, Qiu B, et al. Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells. Am J Physiol 1996;271(5 Pt 1):G884-92.
129. Wilson LM, Baldwin AL. Environmental stress causes mast cell degranulation, endothelial and epithelial changes, and edema in the rat intestinal mucosa. Microcirculation 1999;6:189-98.
130. Castagliuolo I, Wershil BK, Karalis K, et al. Colonic mucin release in response to immobilization stress is mast cell dependent. Am J Physiol 1998;274(6 Pt 1):G1094-100.
131. Grammatopoulos DK, Chrousos GP. Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 2002;13:436-44.
132. Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 2004;44:525-57.
133. Tache Y, Perdu MH. Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil 2004;16(suppl 1):137-42.
134. Leu SJ, Singh VK. Stimulation of interleukin-6 production by corticotropin-releasing factor. Cell Immunol 1992;143:220-7.
135. Singh VK, Leu SJ. Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. Neurosci Lett 1990;120:151-4.
136. Singh VK. Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. J Neuroimmunol 1989;23:257-62.
137. Leu SJ, Singh VK. Modulation of natural killer cell-mediated lysis by corticotropin-releasing neurohormone. J Neuroimmunol 1991;33:253-60.
138. Cantarella G, Lempereur L, Lombardo G, et al. Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors. Br J Pharmacol 2001;134:837-44.
139. Wlk M, Wang CC, Venihaki M, et al. Corticotropin-releasing hormone antagonists possess anti-inflammatory effects in the mouse ileum. Gastroenterology 2002;123:505-15.
140. van Tol EA, Petrusz P, Lund PK, et al. Local production of corticotropin releasing hormone is increased in experimental intestinal inflammation in rats. Gut 1996;39:385-92.
141. Kawahito Y, Sano H, Mukai S, et al. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis. Gut 1995;37:544-51.
142. Muramatsu Y, Fukushima K, Iino K, et al. Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides 2000;21:1799-809.
143. Schwarz SP, Blanchard EB. Evaluation of a psychological treatment for inflammatory bowel disease. Behav Res Ther 1991;29:167-77.
144. Jantschek G, Zeitz M, Pritsch M, et al. Effect of psychotherapy on the course of Crohn's disease. Results of the German prospective multicenter psychotherapy treatment study on Crohn's disease. German Study Group on Psychosocial Intervention in Crohn's Disease. Scand J Gastroenterol 1998;33:1289-96.
145. Milne B, Joachim G, Niedhardt J. A stress management programme for inflammatory bowel disease patients. J Adv Nurs 1986;11:561-7.
146. Whorwell PJ. Hypnotherapy in irritable bowel syndrome. Lancet 1989;1:622.
147. Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut 1987;28:423-5.
148. Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984;2:1232-4.
149. Shetty A, Kalantzis C, Polymeros D, et al. Hypnotherapy for inflammatory bowel disease - a randomised, placebo-controlled trial. Gut 2004;53(suppl VI):A226.